192 related articles for article (PubMed ID: 36994064)
41. Cerebrovascular Involvement in Mucormycosis in COVID-19 Pandemic.
Kulkarni R; Pujari SS; Gupta D; Ojha P; Dhamne M; Bolegave V; Dhonde P; Soni A; Adwani S; Diwan A; Duberkar D; Batra D; Deshpande R; Aurangabadkar K; Palasdeokar N
J Stroke Cerebrovasc Dis; 2022 Feb; 31(2):106231. PubMed ID: 34890962
[TBL] [Abstract][Full Text] [Related]
42. Pathogenetic factors fanning the flames of COVID-19 to cause rhino-orbito-cerebral mucormycosis: An observational study.
Reddy YM; Yeduguri S; Reddy N VS; Parida S; Kamatham SN; Pidaparthi L; Jaiswal SK; Sadhvani B; Tourani V; Kumar S; Challa S; Murthy JM
J Mycol Med; 2022 May; 32(2):101252. PubMed ID: 35134736
[TBL] [Abstract][Full Text] [Related]
43. Risk Factors of COVID-19 Associated Mucormycosis (CAM) in Iranian Patients: A Single-Center Retrospective Study.
Tavakolpour S; Irani S; Yekaninejad MS; Alimardi M; Hasibi M; Abdollahi H; Kazemi MA; Lotfi M; Shahbazian H; Nazemian Yazdi NA; Samimiardestani S; Firouzifar M; Farahbakhsh F; Mirzaee Goodarzi M; Feiz F; Salehinia F
Mycopathologia; 2022 Dec; 187(5-6):469-479. PubMed ID: 36202942
[TBL] [Abstract][Full Text] [Related]
44. Survival in rhino-orbito-cerebral mucormycosis: An international, multicenter ID-IRI study.
Cag Y; Erdem H; Gunduz M; Komur S; Ankarali H; Ural S; Tasbakan M; Tattevin P; Tombak A; Ozturk-Engin D; Tartar AS; Batirel A; Tekin R; Duygu F; Caskurlu H; Kurtaran B; Durdu B; Haciseyitoglu D; Rello J;
Eur J Intern Med; 2022 Jun; 100():56-61. PubMed ID: 35304041
[TBL] [Abstract][Full Text] [Related]
45. COVID-associated rhinocerebral mucormycosis: a retrospective analysis of presentation and outcomes.
Moorthy A; Nayak T; Bachalli PS; Tripathi KK; Dutt SN; Kale P; Bhat P; Suresh PK; Gaikwad R; Raju A; Krishna S; Conjeevaram A; Mehta S; Anil-Kumar A; Haldipur D
Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):713-721. PubMed ID: 35849188
[TBL] [Abstract][Full Text] [Related]
46. Emergence of Cerebral Mucormycosis in the Post-COVID Period: A Detailed Analysis of Risk Factors, Clinical Progression, and Management of This Opportunistic Fungal Infection.
Patel M; Panchal J; Desai C; Shah J; Prajapati B; Patel S
Cureus; 2022 Nov; 14(11):e31220. PubMed ID: 36514560
[TBL] [Abstract][Full Text] [Related]
47. Alternating pattern of rhino-orbital-cerebral mucormycosis with COVID-19 in diabetic patients.
Eker C; Tarkan O; Surmelioglu O; Dagkiran M; Tanrisever I; Yucel Karakaya SP; Ulas B; Onan E; Uguz AH; Ozdemir S
Eur Arch Otorhinolaryngol; 2023 Jan; 280(1):219-226. PubMed ID: 35768700
[TBL] [Abstract][Full Text] [Related]
48. Management Challenge of Rhino-Orbito-Cerebral Mucormycosis in Covid 19 Era: A Prospective Observational Study.
Pippal SK; Kumar D; Ukawat L
Indian J Otolaryngol Head Neck Surg; 2022 Oct; 74(Suppl 2):3485-3491. PubMed ID: 34722223
[TBL] [Abstract][Full Text] [Related]
49. Prevalence, predictors, and outcome of pulmonary mucormycosis in COVID-19 associated rhino orbital mucormycosis in a tertiary care center in South India.
Thanjavur Sethuraman K; Athimanjeri Thiruvengadam J; Ravichandran A; Thoppappatty Sengottaiyan S
Curr Med Mycol; 2023 Sep; 9(3):33-37. PubMed ID: 38361963
[TBL] [Abstract][Full Text] [Related]
50. COVID Associated Mucormycosis: A Study on the Spectrum of Clinical, Biochemical and Radiological Findings in A Series of Ten Patients.
Pal P; Chatterjee N; Ghosh S; Ray BK; Mukhopadhyay P; Bhunia K; Srivastava SR; Adhikari S; Barman D; Banerjee B; Mukhopadhyay M; Pal J
J Assoc Physicians India; 2021 Oct; 69(10):11-12. PubMed ID: 34781648
[TBL] [Abstract][Full Text] [Related]
51. Diabetes mellitus and other underlying conditions in patients with coronavirus disease 2019 associated rhino-orbito-cerebral mucormycosis: a systematic review and meta-analysis.
Zobairy H; Salem MM; Ghajarzadeh M; Mirmosayyeb O; Mirsalehi M
J Laryngol Otol; 2022 Sep; 136(9):788-798. PubMed ID: 35514092
[TBL] [Abstract][Full Text] [Related]
52. Association of Serum Iron Studies in COVID Associated Mucormycosis with Stage of the Disease.
Rao C; R M
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443509
[TBL] [Abstract][Full Text] [Related]
53. Anaesthetic concerns in post-COVID mucormycosis at a tertiary care hospital in India: An observational study.
Lahiri S; Kundu AK; Ray M
Indian J Anaesth; 2023 May; 67(5):471-474. PubMed ID: 37333699
[TBL] [Abstract][Full Text] [Related]
54. Rhino-orbital-cerebral-mucormycosis in COVID-19: A systematic review.
Bhattacharyya A; Sarma P; Sharma DJ; Das KK; Kaur H; Prajapat M; Kumar S; Bansal S; Prakash A; Avti P; Thota P; Reddy DH; Gautam BS; Medhi B
Indian J Pharmacol; 2021; 53(4):317-327. PubMed ID: 34414911
[TBL] [Abstract][Full Text] [Related]
55. The baneful alliance of COVID-19 and mucormycosis: Histopathological concerns.
Singh A; Kumar V; Kumar V; Verma N
Indian J Pathol Microbiol; 2023; 66(1):106-110. PubMed ID: 36656220
[TBL] [Abstract][Full Text] [Related]
56. COVID-19-associated mucormycosis of head-and-neck region: A systematic review.
Kamat M; Datar U; Byakodi S; Kamat S; Vimal Kumar V
J Clin Transl Res; 2022 Feb; 8(1):31-42. PubMed ID: 35187287
[TBL] [Abstract][Full Text] [Related]
57. Is mucormycosis the end? A comprehensive management of orbit in COVID associated rhino-orbital-cerebral mucormycosis: preserving the salvageable.
Keshri A; Mathialagan A; Aishwarya A; Ravisankar ; Bhuskute G; Kanaujia V; Singh AK; Singh RK; Dhiman RK; Agarwal R
Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):819-827. PubMed ID: 36053359
[TBL] [Abstract][Full Text] [Related]
58. Role of COVID 19 Inflammatory Markers in Rhino-Orbito-Cerebral Mucormycosis: A Case Study in Predisposed Patients at a Designated Nodal Centre.
Goddanti N; Reddy YM; Kumar MK; Rajesh M; Reddy LS
Indian J Otolaryngol Head Neck Surg; 2022 Oct; 74(Suppl 2):3498-3504. PubMed ID: 34804904
[TBL] [Abstract][Full Text] [Related]
59. Magnetic Resonance Imaging Features of Rhino-Orbito-Cerebral Mucormycosis in Post-COVID-19 Patients: Radio-Pathological Correlation.
Hassan RM; Almalki YE; Basha MAA; Gobran MA; Alqahtani SM; Assiri AM; Alqahtani S; Alduraibi SK; Aboualkheir M; Almushayti ZA; Aldhilan AS; Aly SA; Alshamy AA
Diagnostics (Basel); 2023 Apr; 13(9):. PubMed ID: 37174937
[TBL] [Abstract][Full Text] [Related]
60. COVID-19-Associated Mucormycosis in a Tertiary Care Hospital in India: A Case Series.
Singh S; Basera P; Anand A; Ozair A
Cureus; 2022 Aug; 14(8):e27906. PubMed ID: 36110469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
